Bringing you the latest cutting-edge research and commentary in bioscience.

Cell & Gene Therapy Insights

Cell & Gene Therapy Insights

Commercial Insight – February 2016

Alan Boyd, Mark Curtis & Rahul Sarugaser Providing a critical overview of the sector’s commercial developments – M&As, licensing agreements & collaborations, financial results, IPOs and clinical/regulatory updates, with commentary from our Expert Contributors. CELL THERAPY: After a prolonged process, Astellas was successful in bringing its takeover bid of Ocata to a close this past […]

Open access
This content is restricted to registered users. Click here to Register or Login here.
Twitter IconVisit Our Blog